Ohio-based Synapse Biomedical, Inc. announces that the U.S. FDA has granted Breakthrough Therapy Device designation to TransAeris, a temporary percutaneous intramuscular diaphragm stimulator designed to aid in weaning from mechanical ventilation.
Read More
Although it remains to be seen how this action will affect the medical device sector, FTC Commissioner Rohit Chopra explicitly mentioned ventilators in a statement, writing: “We heard about hospitals worried that they would be unable to fix a ventilator because a manufacturer was seeking to deny access to repair it. Outages caused by repair restrictions like these can make the difference in times of emergencies.”
Read More
Design engineers at Monolithic Power Systems share with EDN their design process for developing an open-source “emergency ventilator” with a focus on power solutions during the COVID-19 pandemic.
Read More
Elite Medical Experts shares its take on the voluntary recall of specific Philips Respironics ventilators, BiPAP, and CPAP devices.
Read More
Sanjay Jupudi, a Dallas-based software developer at Qentelli, is on a mission to reconfigure old CPAP and BiPAP machines into ventilators to fight the ongoing COVID-19 pandemic.
Read More